Circulating DNA, Circulating RNA, Circulating Tumor Cells

Agenda Topics

• Circulating RNAs as a Potential Biomarker Class (Small RNAs such as microRNAs are an Attractive Biomarker Class)
• Circulating Tumor Cells (CTCs): Methodologies for Isolation and Interrogation
• Head-to-Head Comparison of CTCs with ctDNA as Circulating Biomarkers
• Circulating Tumor DNA (ctDNA): Potential for Monitoring Disease Progression in Oncology
• Circulating-Free DNA (cfDNA) as a Cancer Biomarker for Correctly Deploying Targeted Therapeutics and Enabling Personalized Medicine
• Digital PCR Applications for Circulating Biomarker Interrogation
• Methodologies for Isolating and Characterizing Extracellular Nucleic Acids (cfDNA, Extracellular RNA)
• Tools and Technologies for Monitoring Extracellular Nucleic Acids in Biological Fluids

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Tania Konry, Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University
Martin Beaulieu, Director, Regulus Therapeutics Inc
Farideh Bischoff, Executive Director, Silicon Biosystems Inc
Cesar Castro, Director – Cancer Program, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School
Saumya Das, Assistant Professor in Medicine, Beth Israel Deaconess Medical Center and Mass General Hospital
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Z Fan, Professor, University of Florida
Tony Godfrey, Associate Chair – Research, Department of Surgery, Boston University Medical Center
Kenneth Kotz, Assistant in Bioengineering & Instructor, Massachusetts General Hospital/Harvard Medical School
Pavan Kumar, Senior Scientist, Eisai Inc
Mike Makrigiorgos, Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School
Abhijit Patel, Associate Professor, Yale University School of Medicine
Meeta Patnaik, CMO, AXON Dx
Kristin Ciriello Pothier, Partner & Managing Director/Life Sciences Leader, Ernst and Young LLP
Lidong Qin, Professor and CPRIT Scholar, Houston Methodist Research Institute
Katherine Richardson, Vice President, Research & Development, Transgenomic, Inc.
Jeff Stoll, Vice President, Life Sciences, Ernst & Young LLP
Shannon Stott, Assistant Professor, Massachusetts General Hospital & Harvard Medical School
Alexander Wolf, Scientist, QIAGEN
Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics
Weian Zhao, Associate Professor, Department of Biomedical Engineering, University of California-Irvine